UNIT-II Aminoglycosideantibiotics
UNIT-II Aminoglycosideantibiotics
UNIT-II Aminoglycosideantibiotics
net/publication/321938027
CITATIONS READS
0 2,414
1 author:
Dr Sumanta Mondal
GITAM (Deemed to be University)
191 PUBLICATIONS 266 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Dr Sumanta Mondal on 20 December 2017.
Streptomycin: It is used in the treatment of infections caused by gram-negative bacteria of particular interest
and has a high degree of activity against P. aeruginosa, where the important causative factor is burned skin. It is
used topically in the treatment of infected bed-sores, pyodermata, burns, and in the eye infection.
Neomycin: It is photosensitive and its main use is in the treatment of the ear, eye, and skin infections; these
include burns, wounds, ulcer, and infected dermatoses.
Kanamycin: The kanamycins do not possess D-ribose molecule. The use of kanamycins is restricted to
infections of the intestinal tract and to systemic infections.
Tobramycin: Its activity is similar to gentamycin. The superior activity of tobramycin against P. aeruginosa
may make it useful in the treatment of bacterial oesteromyelitis, and pneumonia caused by Pseudomonas species.
i. The bacterial inactivating enzymes targets C-6 and C-2 position and the substitution with methyl group at C-6
increases the enzyme resistance.
ii. Cleavage of 3-hydroxyl or the 4-hydroxyl or both groups does not affect the activity.
i. Various modifi cations at C-1 amino group have been tested. The acylation (e.g. amikacyn) and ethylation (e.g.
1-N-ethylsisomycin) though does not increase the activity helps to retain the antibacterial potency.
ii. In sisomicin series, 2-hydroxylation and 5-deoxygenation result in the increased inhibition of bacterial
inactivating enzyme systems. Thus, very few modifications of the central ring are possible, which do not violate
the activity spectrum of aminoglycosides.